Cargando…

Cardiac biomarkers in the field of cardio-oncology

Detalles Bibliográficos
Autores principales:	Cardinale, Daniela, Mills, Nicholas L, Mueller, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Biomarker Spotlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709630/ https://www.ncbi.nlm.nih.gov/pubmed/36215174 http://dx.doi.org/10.1093/ehjacc/zuac126

Ejemplares similares

How to use cardiac troponin in non-cardiac surgery
por: Puelacher, Christian, et al.
Publicado: (2023)

Cardiac troponin T and I: back to basics
por: Mingels, Alma M, et al.
Publicado: (2023)

How is cardiac troponin released from cardiomyocytes?( )
por: Hammarsten, Ola, et al.
Publicado: (2022)

Cardio‐Oncology at the Beginning of a New Decade
por: Grumbach, Isabella M.
Publicado: (2020)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
por: Visaria, Aayush, et al.
Publicado: (2022)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study
por: Welsh, Paul, et al.
Publicado: (2017)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

Precision oncology for upper GI cancers – Where are we heading?
por: Quante, Michael
Publicado: (2021)

Biomarkers in Routine Heart Failure Clinical Care
por: Nadar, Sunil K, et al.
Publicado: (2019)

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016)

Urinary miRNA Biomarkers of Drug-Induced Kidney Injury and Their Site Specificity Within the Nephron
por: Chorley, Brian N, et al.
Publicado: (2020)

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
por: Maisel, Alan S., et al.
Publicado: (2011)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

Blood Neurofilament Light Chain as a Potential Biomarker for Central and Peripheral Nervous Toxicity in Rats
por: Sano, Tomoya, et al.
Publicado: (2021)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

Profiling Secreted miRNA Biomarkers of Chemical-Induced Neurodegeneration in Human iPSC-Derived Neurons
por: You, Dahea, et al.
Publicado: (2022)

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy
por: Tolosana, Jose María, et al.
Publicado: (2010)

Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study
por: Teo, Ying Xin, et al.
Publicado: (2022)

Superior vena cava isolation with pulsed field ablation in the presence of defibrillator leads
por: Tsiachris, Dimitrios, et al.
Publicado: (2023)

Accountability in promoting representation of historically marginalized racial and ethnic populations in the eating disorders field: A call to action
por: Goel, Neha J., et al.
Publicado: (2022)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models
por: Sitnikova, Suzanne Isabelle, et al.
Publicado: (2021)

Short‐time ventricular tachycardia ablation for cardiac sarcoidosis using coherent map
por: Hiruma, Takashi, et al.
Publicado: (2022)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device
por: Morley-Smith, Andrew C, et al.
Publicado: (2014)

Magnetic resonance imaging in a patient with cardiac resynchronization therapy‐defibrillator and two abandoned leads
por: Lüsebrink, Enzo, et al.
Publicado: (2022)

The Role of Biomarkers in Cardio-Oncology
por: Ananthan, Kajaluxy, et al.
Publicado: (2020)

Potential feasibility of a novel over‐the‐wire microelectrode catheter for recording coronary sinus electrograms in patients with cardiac resynchronization therapy devices
por: Okada, Masato, et al.
Publicado: (2023)

Ventricular fibrillation count by noise oversensing in a cardiac resynchronization therapy‐defibrillator induced by side branch protection during percutaneous coronary intervention
por: Tanabe, Sho, et al.
Publicado: (2022)

Race, ancestry, and genetic risk for kidney failure
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology
por: Alvarez-Cardona, Jose A., et al.
Publicado: (2020)

Think globally, act locally: Centrosome-localized mRNAs ensure mitotic fidelity
por: Zarnescu, Daniela C.
Publicado: (2020)

Successful cardiac synchronization therapy device upgrade using an active fixation quadripolar pacing lead in a patients with persistent left superior vena cava and absent right superior vena cava
por: Nishiwaki, Shushi, et al.
Publicado: (2023)

Bedside biomarkers in pediatric cardio renal injuries in emergency
por: Singhal, Noopur, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p34gvv5lm9mrumm7laa416tmd4